CTC
BEAT

Central Trust Company’s BioTelemetry, Inc. BEAT Stock Holding History

Central Trust Company’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-149
Closed -$7K – 1132
2020
Q2 		$7K Buy
149
+30
+25% +$1.34K ﹤0.01% 888
2020
Q1 		$5K Sell
119
-110
-48% -$5.06K ﹤0.01% 997
2019
Q4 		$11K Sell
229
-32
-12% -$1.39K ﹤0.01% 940
2019
Q3 		$11K Sell
261
-7
-3% -$302 ﹤0.01% 896
2019
Q2 		$13K Buy
268
+40
+18% +$2.1K ﹤0.01% 878
2019
Q1 		$14K Buy
228
+8
+4% +$550 ﹤0.01% 833
2018
Q4 		$13K Sell
220
-50
-19% -$3K ﹤0.01% 852
2018
Q3 		$17K Sell
270
-50
-16% -$2.79K ﹤0.01% 876
2018
Q2 		$14K Sell
320
-70
-18% -$2.79K ﹤0.01% 907
2018
Q1 		$12K Buy
390
+290
+290% +$9.54K ﹤0.01% 948
2017
Q4 		$3K Hold
100
– – ﹤0.01% 1171
2017
Q3 		$3K Buy
+100
New +$3.46K ﹤0.01% 1140
2017
Q2 		– Sell
-1,380
Closed -$40K – 1367
2017
Q1 		$40K Buy
+1,380
New +$34.2K ﹤0.01% 776

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Central Trust Company's BEAT Position: Q3 2020 in Review

Central Trust Company sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 149 shares — an estimated $7K sold.

Central Trust Company first reported a position in BEAT in Q1 2017 and held it in 13 quarters. The position peaked at $40K in Q1 2017. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • Central Trust Company reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • Central Trust Company sold 149 BioTelemetry, Inc. shares in Q3 2020, an estimated $7K.
  • Central Trust Company first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 13 quarters.
  • Central Trust Company's BioTelemetry, Inc. position peaked at $40K in Q1 2017.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Central Trust Company's 13F filing for Q3 2020, filed 22 Oct 2020.